Novartis and Breckenridge drop cancer drug dispute
10-08-2018
Bayer and Ginkgo team up to boost sustainable agriculture
19-09-2017
Lukassek / Shutterstock.com
Bayer and Janssen Pharmaceuticals have sued Breckenridge Pharmaceutical for allegedly infringing two patents related to the deep vein thrombosis treatment drug Xeralto (rivaroxaban).
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Bayer, Janssen, Breckenridge, Xeralto, patent, ANDA,
